Sleyster Scott
Known title: Executive Vice PresidentCIK: 0001555872
Associated companies
this person other insiders at PFH
Transaction History
| PFH | ▼ Sell | Tax Withholding | 2,186 | $244K | 2/28/2022 | View on chart |
| PFH | ▲ Buy | Option Exercise | 4,503 | $0 | 2/28/2022 | View on chart |
| PFH | ▲ Buy | Option Exercise | 8,659 | $732K | 2/9/2022 | View on chart |
| PFH | ▲ Buy | Option Exercise | 23,983 | $1.4M | 2/9/2022 | View on chart |
| PFH | ▼ Sell | Open Market | 20,912 | $2.5M | 2/9/2022 | View on chart |
| PFH | ▼ Sell | Open Market | 8,039 | $973K | 2/9/2022 | View on chart |
| PFH | ▼ Sell | Other | 6,228 | $755K | 2/9/2022 | View on chart |
| PFH | ▲ Buy | Option Exercise | 22,884 | $0 | 2/8/2022 | View on chart |
| PFH | ▼ Sell | Tax Withholding | 10,474 | $1.3M | 2/8/2022 | View on chart |
| PFH | ▲ Buy | Option Exercise | 16,448 | $977K | 11/11/2021 | View on chart |
| PFH | ▲ Buy | Option Exercise | 5,935 | $283K | 11/11/2021 | View on chart |
| PFH | ▼ Sell | Open Market | 22,383 | $2.5M | 11/11/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 9, 2026
Prudential Financial Discusses Japan Business Update After FSA Orders
Prudential Financial released a transcript of a discussion about its Japan operations. The company explained the steps it is taking after orders from the Financial Services Agency, including remediation measures and a plan for moving forward. These updates give investors a clearer view of how regulatory actions may affect the insurer’s business and its long‑term strategy.
Prudential Financial Discusses Japan Business Update After FSA Orders. Prudential Financial released a transcript of a discussion about its Japan operations. The company explained the steps it is taking after orders from the Financial Services Agency, including remediation measures and a plan for moving forward. These updates give investors a clearer view of how regulatory actions may affect the insurer’s business and its long‑term strategy.